Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
247.88B | 263.35B | 271.55B | 232.31B | 232.39B | Gross Profit |
109.36B | 101.60B | 113.30B | 100.75B | 93.72B | EBIT |
0.00 | 11.98B | 27.08B | 31.78B | 27.81B | EBITDA |
16.16B | 27.96B | 36.55B | 38.92B | 36.81B | Net Income Common Stockholders |
20.00M | -26.45B | 18.72B | 22.69B | 17.48B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
60.76B | 44.77B | 47.09B | 66.98B | 50.43B | Total Assets |
292.37B | 297.04B | 349.54B | 305.61B | 271.53B | Total Debt |
45.54B | 54.33B | 42.23B | 41.13B | 39.46B | Net Debt |
1.65B | 19.14B | 3.88B | -12.92B | -4.15B | Total Liabilities |
199.39B | 199.63B | 216.23B | 198.51B | 186.35B | Stockholders Equity |
94.28B | 98.67B | 134.81B | 108.78B | 86.67B |
Cash Flow | Free Cash Flow | |||
42.62B | 3.88B | 24.67B | 34.44B | 23.62B | Operating Cash Flow |
46.26B | 7.18B | 30.86B | 39.06B | 28.93B | Investing Cash Flow |
-15.95B | -8.71B | -34.40B | -19.88B | -15.20B | Financing Cash Flow |
-23.86B | 1.01B | -15.93B | -9.31B | -12.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $231.26B | 25.47 | 20.02% | 2.75% | -5.34% | -30.57% | |
75 Outperform | $25.23B | 20.00 | 8.27% | 2.04% | -12.68% | 90.73% | |
73 Outperform | $69.66B | 45.18 | 129.87% | 0.99% | 8.41% | -7.83% | |
73 Outperform | $23.07B | 12,050.00 | 0.15% | 2.39% | -5.59% | ― | |
67 Neutral | $19.05B | 7.17 | 12.09% | 3.59% | 10.93% | 43.19% | |
60 Neutral | $11.71B | 40.85 | 6.21% | 2.50% | -8.82% | -10.01% | |
57 Neutral | $20.24B | 9.51 | -13.28% | 2.72% | 5.43% | -24.54% |